Home/Critical Appraisal
Critical Appraisal

Case Series & Case Reports

EM FINAL EXAMS Critical Appraisal · Study design Case Series & Case Reports A detailed description of one (case report) or a handful (case series) of patients — no control group, no comparison. Definition Purely descriptive accounts of the clinical course of a single patient (case report) or several similar patients (case series). There is […]

EM FINAL EXAMS Critical Appraisal · Study design

Case Series & Case Reports

A detailed description of one (case report) or a handful (case series) of patients — no control group, no comparison.

Definition

Purely descriptive accounts of the clinical course of a single patient (case report) or several similar patients (case series). There is no comparator and no denominator, so they sit at the base of the evidence pyramid. Their job is to generate hypotheses, not to test them.

The picture
1 2 3 4 5 6 Systematic reviews & meta-analyses RCTs Cohort studies Case-control studies Case series & reports Expert opinion higher = lower risk of bias

Case series & reports sit near the base — weakest tier, but often the first signal.

What it shows

Where descriptive reports sit relative to comparative designs. They are the broadest, weakest tier for proving cause and effect — one step above expert opinion — precisely because there is no control group to say what would have happened anyway.

How to read it

Read the position as a warning about internal validity, not value. A case report describes one patient; a case series collects several with a shared feature. Neither has a denominator or comparator, so you cannot calculate risk, rates or any effect measure from them — only describe.

Why it matters

Despite the low tier, they are invaluable: they describe rare conditions and novel presentations, teach pattern recognition, and provide the first signal of a new disease or a serious adverse drug effect — signals that later, stronger studies are built to confirm or refute.

Key
  • Case report = 1 patient; case series = several
  • No comparator, no denominator → hypothesis-generating
  • Best for rare conditions & first adverse-effect signals
Pitfall
Pitfall Drawing causal or efficacy conclusions from an uncontrolled description. With no comparison group you cannot know the outcome was due to the treatment rather than natural history, and selection & recall bias make a tidy series look more convincing than it is.
emfinalexams.com · FRCEM / MRCEM revision
EM trial in the wild

Thalidomide — McBride, Lancet (16 Dec 1961) — a one-paragraph letter reporting a cluster of newborns with the same rare limb-reduction defect (phocomelia) whose mothers had taken thalidomide in pregnancy. This handful of uncontrolled observations was enough to raise the alarm and drive the drug’s withdrawal — a textbook example of a case series delivering the first signal of a catastrophic adverse effect. The series flagged the danger; it could not prove it — causation was established afterwards by systematic epidemiology. A case series sounds the alarm, it does not return the verdict.

Examiner traps
  • Treating a case series as efficacy evidence — with no comparator it can never show a treatment works.
  • Confusing a case series (descriptive, no controls) with a case-control study (analytical, has controls).
  • Ignoring selection & publication bias — striking cases get written up; the unremarkable ones never do.
Quick check

Can a case series prove that a treatment works?
Answer: No — there is no comparator group, so you cannot know whether the outcome was due to the treatment or would have happened anyway. A case series can only generate the hypothesis that a controlled study then tests.

Related cards

Ready to build your plan? EMF Premium gives you all 40,000+ questions, 20 mocks and 1,215 OSCE stations from £29/month — or a one-off 3- or 6-month pass.

Share
0
    0
    Your Cart
    Your cart is emptyReturn to Shop